IN THE NEWS: Zafgen Completes Enrollment of U.S. Phase 3 Trial of Beloranib in Prader-Willi Syndrome

http://pipelinereview.com/index.php/2015052857849/Small-Molecules/Zafgen-Completes-Enrollment-of-U.S.-Phase-3-Trial-of-Beloranib-in-Prader-Willi-Syndrome.html

Advertisements

One thought on “IN THE NEWS: Zafgen Completes Enrollment of U.S. Phase 3 Trial of Beloranib in Prader-Willi Syndrome

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s